 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- |||| CNM-ZnAg / Clene Nanomedicine
Trial completion: Study of ZnAg Liquid Solution to Treat COVID-19 Symptomatic Participants (clinicaltrials.gov) - Feb 8, 2023
P2, N=296, Completed, Sponsor: Clene Nanomedicine
Active, not recruiting --> Completed
- || CNM-ZnAg / Clene Nanomedicine
Trial completion date: Study of ZnAg Liquid Solution to Treat COVID-19 Symptomatic Participants (clinicaltrials.gov) - Jul 19, 2022
P2, N=276, Active, not recruiting, Sponsor: Clene Nanomedicine
Active, not recruiting --> Completed Trial completion date: May 2022 --> Aug 2022
- ||| CNM-ZnAg / Clene Nanomedicine
Enrollment closed, Trial completion date, Trial primary completion date: Study of ZnAg Liquid Solution to Treat COVID-19 Symptomatic Participants (clinicaltrials.gov) - Mar 29, 2022
P2, N=276, Active, not recruiting, Sponsor: Clene Nanomedicine
Trial completion date: May 2022 --> Aug 2022 Not yet recruiting --> Active, not recruiting | Trial completion date: Aug 2021 --> May 2022 | Trial primary completion date: Jul 2021 --> May 2022
- ||||| CNM-ZnAg / Clene Nanomedicine
New P2 trial: Study of ZnAg Liquid Solution to Treat COVID-19 Symptomatic Participants (clinicaltrials.gov) - Oct 29, 2020
P2, N=238, Not yet recruiting, Sponsor: Clene Nanomedicine